The Company is utilizing its proprietary 212Pb generator to expand its regional network of drug product finishing facilities, which can improve the capacity for clinical trials and commercial ...

Currently, the company’s melanoma (VMT01) and neuroendocrine tumor (VMT-α-NET) programs are undergoing Phase 1/2a trials, and the company has created a proprietary 212Pb generator to support ...

today announces that it has developed and validated a breakthrough generator technology for the production of lead-212 (212Pb) and successfully completed first production. Telix Pharmaceuticals ...

[212Pb]VMT01 is being tested in combination with Opdivo in a phase 1/2a trial for melanoma patients with positive MC1R imaging scans. The FDA granted fast track designation to [212Pb]VMT01 for ...

OpenAI’s new image generator, powered by its GPT-4o model, is now available to all users, CEO Sam Altman said in a post on X. The feature was until now available only to paying users of ChatGPT.

This month, ChatGPT unveiled a new image generator as part of its 4o model that is a lot better at generating text inside images. People are already using it to generate fake restaurant receipts ...

The biggest stories of the day delivered to your inbox.

Shares of Perspective Therapeutics have declined due to market disappointment with interim data for its lead candidate, [212Pb]VMT-α-NET. The company's pipeline centers on [212Pb]VMT-α-NET ...

However, there was one glaring omission: A really capable image generator. Last week, OpenAI launched 4o image generation. This image model is significantly better -- albeit slower -- than the ...